The host inflammatory response to chronic bacterial infections often dictates the disease outcome. In the case of the gastric pathogen Helicobacter pylori, host inflammatory responses result in outcomes that range from moderate and asymptomatic to more severe with concomitant ulcer or cancers. It was found recently that H. pylori chemotaxis mutants (Che − ), which lack directed motility but colonize to nearly wild-type levels, trigger less host inflammation. We used these mutants to observe host immune responses that resulted in reduced disease states. Here we report that these mutants are defective for early gastric recruitment of CD4 + T cells compared with wild-type infection. Furthermore, Che − mutant infections lack the Thelper cell, type 17 (Th17) component of the immune response, as measured by cytokine mRNA levels in gastric tissue via intracellular cytokine staining and immunofluorescence. We additionally find that a Che − mutant infection results in significantly less host cell apoptosis than does wild-type infection, in accordance with previous observations that T-helper cell, type 17 responses in Citrobacter rodentium infections are driven by concomitant bacterial and apoptotic cell signals. We propose that bacterial chemotaxis allows H. pylori to access a particular host niche that allows the bacteria to express or deliver proapoptotic host cell factors. This report indicates that chemotaxis plays a role in enhancing apoptosis, suggesting bacterial chemotaxis systems might serve as therapeutic targets for infections whose symptoms arise from host cell apoptosis and tissue damage.
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T regulatory cells | adaptive immunity | pathogenesis I nfection with the gastric pathogen Helicobacter pylori leads to chronic inflammation, or gastritis, in all individuals. This bacterium colonizes 50% of the world's population and triggers a wide range of disease severities; many infected individuals remain asymptomatic, but others develop peptic or gastric ulcers, gastric adenocarcinoma, or mucosa-associated lymphoid tumors (1) .
The pathogenesis of H. pylori-induced inflammation is not well understood. Inflammation is promoted by both host factors (2) and H. pylori factors, such as the proteins cytotoxin associated gene A (CagA) (1, 2) and vacuolating cytotoxin A (VacA) (1, 3) and bacterial chemotaxis (4) . Chemotaxis is the bacterial ability to move toward beneficial environmental signals and away from harmful ones. H. pylori genetically altered to lack chemotaxis (Che − ) retain flagella and motility but cannot migrate toward or away from environmental signals. In mouse models, these mutants have a marginal colonization defect (4-6) but induce less overall chronic inflammation (4). Specifically, Che − mutants localize far from the epithelial surface and do not colonize the gastric glands robustly (4, 6) , suggesting that chemotaxis-driven contact with epithelial cells, resident dendritic cells, or monocytes promotes the inflammatory response to H. pylori.
Inflammation begins when resident monocytes and epithelial cells detect injury or a pathogen such as H. pylori (7) . Epithelial cells secrete chemokines to recruit antigen-presenting cells (APCs) such as dendritic cells that will prime T cells (7) . The newly recruited APCs define the immune response to H. pylori based on the nature of their contact with the pathogen, because the APCs produce cytokines that dictate the character of the adaptive immune response. Dendritic cells interacting with H. pylori fuel the proliferation of particular T cells, including T helper cells, type 1 (Th1 cells) (8) , CD25 +
FoxP3
+ T-regulatory cells (T-regs) (8, 9) , and T helper cells, type 17 (Th17 cells) (10).
The inflammatory response to H. pylori includes all these T-cell types. However, the roles of the Th17 and T-reg cell populations during H. pylori infections have been debated recently. The Th17 cell is involved in promoting chronic inflammation (11, 12) ; the Treg cell, in contrast, regulates host immune responses. Th17 and Treg cells are developmentally related and exist in a delicate balance (13) that can dictate the outcome of a bacterial infection (14) . Evidence suggests that H. pylori pathogenesis results primarily from the immune response, and thus understanding how this immune response is initiated and controlled is critical. Currently it is unknown if a Th17 response (12) or a T-reg response (9) underlies the ineffective immune response to H. pylori. Therefore, we sought to understand better how H. pylori promotes gastritis by comparing the host immune cell and cytokine responses to wild-type H. pylori and to a Che − mutant. Our studies provide evidence that bacterially driven interactions with host tissues alter the nature of the immune and pathological response generated during infection.
Results and Discussion
H. pylori Chemotaxis Increases Inflammation 2 mo After Inoculation.
As stated above, Che − H. pylori cause milder inflammation than do wild-type infections after 3-6 mo of colonization (4) . To determine whether bacterial chemotaxis affected inflammation earlier, we examined inflammation at the earliest time inflammation was detectable, 2 mo after inoculation. For these experiments, we orally infected mice with either wild-type H. pylori or an isogenic Che − mutant lacking a central chemotaxis protein, CheY. H. pylori cheY mutants have been characterized extensively and found to retain flagella and motility but to lack chemotaxis completely (5, 15) . Che − mutants have early mouse colonization defects but achieve normal bacterial levels by 1 mo after inoculation (5, 16) . All cheY mutant-associated phenotypes can be complemented, indicating that loss of cheY is responsible for the chemotaxis and animalcolonization deficits (5, 15) . Using standard inflammation grading that captures the number and distribution of lymphocytes, we found that inflammation was significantly lower in mice infected for 2 mo with Che − H. pylori than in mice infected with wild-type H. pylori but was greater than in the no-H. pylori control (Fig. 1 ). Overall scores at this time point are low, confirming that 2 mo after inoculation is the earliest time point at which inflammation is pathologically identifiable. Bacterial numbers at 2 mo after inoculation in both infection groups were ∼1 × 10 6 cfu/g and did not differ significantly from each other, similar to previous findings (4, 5) , suggesting that inflammatory differences are not caused by a disparity in bacterial burden. Additionally, there was no correlation within individual mice between bacterial colonization levels and inflammation grade, as seen previously (4). This finding thus suggests that Che − inflammatory deficits arise before 2 mo of infection.
Che − H. pylori Inefficiently Recruits CD4 + T Cells. We were curious about the exact cell types that are reduced in the Che − infection. Numerous studies have found that T cells are the dominant lymphocyte in an H. pylori infection (8) so we examined T-cell subsets in detail using both flow cytometry and immunohistochemistry.
We infected mice with either wild-type or Che − H. pylori and allowed infections to proceed for 2 wk to 3 mo. The total T-cell populations (CD3 + CD45 + ) in infected stomachs rose steadily from week 2 to week 5 and displayed a subtle trend for the wild type to recruit more T cells than the Che − mutant (Fig. S1A) . Additionally, the percentage of CD4 + T cells remained at background levels in Che − infections but increased significantly above background in wild-type H. pylori infections (Fig. S1B) . T-cytotoxic cells (CD8 + CD3 + ) never increased over the mock-infection control and were not different between the wild-type and Che − infections (Fig. S1B ), in agreement with previous reports that this T-cell type does not play a major role in H. pylori immunity (17) .
When we extended our flow cytometric analysis to 3 mo after inoculation, we observed that the percentage of CD4 + T cells in the Che − infection had risen to match those in the wild-type infection, suggesting that CD4 + T-cell recruitment is delayed but not abrogated in Che − infections ( Fig. 2 A and B) . To verify our flow cytometry result, we further used immunohistochemistry at 2 mo after inoculation and indeed confirmed that wild-type and Che − H. pylori recruited similar numbers of CD4 + cells at this later time ( Fig. 2 C and D) . However, we did observe slight differences in the distribution of CD4 + cells between the two infection types, with wild-type infections bearing more widespread inflammatory cells (Fig. 2C) . Overall, these findings show that early Che − infections recruit fewer CD4 + T cells than do wild-type infections. This difference dissipates sometime between 5 and 8 wk after inoculation, but significant differences in the inflammation grading remain. The inflammation grading method examines lymphocyte density in gastric tissue, and thus our score differences suggest that Che − inflammation is more multifocal in character, whereas wild-type inflammation is more widespread (Materials and Methods) (Fig. 2C ).
H. pylori Chemotaxis Affects Gastric Cytokine Profiles. CD4 + T cells comprise different subsets that play distinctive roles during infection. Therefore, we examined total gastric tissue for the types of These data were subjected to Grubbs' statistical outlier test, which resulted in the removal of one wild-type and one mock infection data point. Wild-type infection, n = 5 mice; Che − infection, n = 6 mice; mock infection, n = 2 mice.
CD4
+ T cells present by monitoring transcripts of genes encoding cytokines and transcription factors associated with Th1 (IFN-γ), Thelper, type 2 (Th2; IL-4), Th17 [IL-6, IL-17A, TGF-β, and related orphan receptor-γT (Rorγt)], and T-reg [IL -10, TGF-β, and forkhead box P3 (Foxp3)] cells. IL-6 and TGF-β are required for Th17 cell differentiation, whereas T-regs require only TGF-β (13) . Examining the induction of the Th17-specific transcription factor Rorγt (13) and the production of IL-17A further identifies IL-17-producing cells. We additionally assessed T-cell activation by monitoring IL-2.
Two months after inoculation, when both infection types had equal numbers of CD4 + cells (Fig. 2) , stomachs infected with wildtype H. pylori displayed statistically significant increases in mRNA for Il10 and the Rorγt-encoding gene Rorc as well as a strong increase in Il17a, IL6, and Foxp3 compared with levels in the Che − -infected stomach, which remained at the levels occurring in mockinfected stomachs (Fig. 3 A and B) . Rorγt, IL-17A, and IL-6 are associated with IL-17-producing cells, suggesting that the wildtype infection skews the response toward IL-17-producing cells. Tgfβ and Foxp3 (Fig. 3 ) levels in wild-type and Che − H. pylori infections were not altered significantly from the levels in mock infection, but Il10 was up-regulated significantly in the wild-type infection, suggesting that T-regs may be more active in a wild-type than in a Che − H. pylori infection. The presence of T-regs in H. pylori infection has been well established (8) , but their role in the outcome of the immune response still is debated. Additionally, Th1 and Th2 cells secrete IL-10 as a way to control their responses (18) , and Th17 cells also have been shown to produce IL-10 under some circumstances (19) .
Because we observed the up-regulation of Il10, a regulatory cytokine, we additionally determined the ratio of Rorc to Foxp3 to assess whether the immune response is more inflammatory or regulatory in character; higher ratios of Rorc:Foxp3 indicate that the immune response trends toward inflammatory. This parameter also has been examined as the Il17a:Foxp3 ratio (9). We found that the both the Rorc:Foxp3 ratio and the Il17a:Foxp3 ratio are higher in the wild-type infection than in the Che − infection and the mock infection (Fig. 3C ). This finding is consistent with previous evidence showing IL-17 expression in H. pylori-infected gastric tissue (9, 12, 17) . Furthermore, studies have shown that depletion of IL-17 or the use of IL-17 −/− mice lowers both H. pylori colonization levels and inflammation grade (12) .
Chemotactic H. pylori Induces a Th17 Response. Although the quantitative PCR (qPCR) data for IL6, IL17a, and Rorc suggest that key cytokines critical for the development and activation of the Th17 subset are significantly elevated in the wild-type infection, qPCR of total gastric tissue cannot specifically identify the cellular cytokine source. IL-17A, for example, is secreted from Th17 cells as well as from γδ T cells (20) and lymphoid tissue-inducer (LTi) cells (21) . We therefore performed intracellular cytokine staining to assess which gastric tissue lymphocytes produce IL-17A. To accomplish this goal, we sorted CD45 + live cells from gastric tissue of H. pylori-infected mice, stimulated them, and subsequently stained them with the surface markers CD3, CD4, and CD45 and the cytokine IL-17A. In wild-type H. pylori infections, IL-17A-producing cells were detected within the CD4 + cells after gating on CD3 + CD45
+ populations, consistent with Th17 cells (Fig. 4 A  and B) . A smaller population of IL-17A-producing cells also was detected with in the CD4
+ populations, suggesting secretion by CD3 + γδ T cells, given that there are few CD8 T cells in these infections (Fig. S1) . No IL-17A production was detected within the CD3 −
CD45
+ populations from either wild-type-or Che − -infected mice, suggesting that LTi cells, which lack CD3 (21), were not the source of IL-17A production at this time point (Fig. S2) . Other types of innate lymphoid cells have been shown to drive intestinal pathology in a Helicobacter hepaticus model (22); thus it would be interesting to look at earlier time points to see if LTi cells contribute to the initiation of adaptive responses to H. pylori. We also performed an immunofluorescence study looking for the colocalization of CD4 and IL-17A in gastric tissue slices from mice 2 mo after infection (Fig. 4 C and D) . This experiment confirmed the results of intracellular cytokine staining, finding that CD4 and IL-17A were colocalized to a significant degree in tissue infected with wild-type H. pylori (Fig. 4 C and D) . We detected only few cells that, as would γδ T cells, stained solely with IL-17A and not CD4; this finding is consistent with a low number of γδ T cells in wild-type and Che − H. pylori infections (Fig. S3 ) and supports a principal role for Th17 cells. Together the results from the intracellular cytokine staining, the immunofluorescence assay, and the gastric cytokine analysis strongly indicate that the Th17 subset is elevated significantly in stomachs with wild-type H. pylori infection as compared with stomachs with either Che − H. pylori or mock infection. These findings suggest a role for bacterial chemotaxis in eliciting a Th17 response. Th17 responses have been implicated in Citrobacter rodentium (23) and Salmonella enterica serovar Typhimurium infections (24) , where these responses seem to underlie pathology.
Chemotaxis Promotes Apoptosis in H. pylori Infection. Th17 cell differentiation is directed in part when innate immune cells, such as APCs, recognize apoptotic cells combined with bacterial pro- ducts that activate Toll-like receptors (24) . In addition to apoptosis, Th17 development also is associated with IL-10 induction (24); we observed high IL-10 levels in the wild-type infection (Fig.  3A) . Thus, one possibility is that wild-type H. pylori triggers significant apoptotic cells and in turn Th17 induction. To probe this hypothesis, we enumerated apoptotic cells in gastric tissue by TUNEL staining 2 mo after inoculation, when equal numbers of wild-type and Che − bacteria colonize the stomach and there are differences in the degree of Th17 response (Figs. 3 and 4) . We found elevated apoptosis in the corpus associated with wild-type H. pylori in comparison with Che − (Fig. 5 A and B) . Although apoptosis has been demonstrated previously in several bacterial infections, including H. pylori (25) , the link to Th17 responses has been demonstrated only in C. rodentium infections (24) . C. rodentium strains are generally nonmotile (26) , and instead use type-three secretion-based adherence to deliver proapoptotic factors (27) . We can now link apoptosis in H. pylori infection to bacterial chemotaxis and Th17 responses.
H. pylori can induce apoptosis in epithelial cells and macrophages through secretion of proapoptotic factors including the VacA cytotoxin (3), urease (28) , and γ-glutamyl transpeptidase (29) and by up-regulating Fas, a TNF receptor that triggers apoptosis of host cells when bound by its ligand, FasL (30) . Therefore, our results suggest Che − bacteria express or deliver less proapoptotic virulence factors in vivo. Che − H. pylori localize farther from the gastric epithelial cell surface than does wild type (4, 6) suggesting Che − either may be too spatially distant from the target cells for efficient delivery of virulence factors or may experience a different microenvironment that does not trigger appropriate expression of apoptosis-inducing proteins. Supporting this latter idea, chemotaxis regulates virulence factor expression in Vibrio cholerae (31) .
To investigate if different mechanisms leading to apoptosis vary in wild-type and Che − H. pylori, we looked at the gastric mRNA expression of Fas, which is up-regulated and contributes to apoptosis in H. pylori infection (30) , and its ligand, FasL. We found that after 2 mo of infection the expression of Fas in wild-type and Che − H. pylori infections is similar to that seen in an uninfected mouse (Fig. S4) . Additionally, wild-type and Che − infections lead equally to up-regulation of FasL (Fig. S4) , indicating that Fas/ FasL-induced cell death does not contribute to apoptotic differences seen in gastric tissue. We also examined the expression of the H. pylori apoptosis-causing virulence factors VacA and urease (subunit) A (UreA) in mouse stomachs after 2-mo infection (Fig. S5) . We , and mock infections, respectively. Each bar represents the mean ± SEM. *P < 0.05; Student's t test. N.S., not significant. Two independent infections were used to generate the data for A and B and for C and D.
found that on average Che − bacteria have a somewhat lower expression of VacA but a somewhat higher expression of UreA than wild-type bacteria (Fig. S5) . The expression of UreA is regulated by the acid-responsive signaling regulator/sensor (ArsRS) twocomponent system, which prompts pH-controlled gene expression (32) . Therefore, because Che − bacteria are farther from the epithelial cells (4, 6) where they may encounter a more acidic pH, it is not surprising that they have slightly increased expression of UreA. The slightly lower expression of VacA along with a greater delivery distance may contribute to reduced apoptosis through reduced delivery of VacA to the epithelial cells. Interestingly another virulence factor, the cytotoxin gene-associated pathogenicity island (cag-PAI) has been associated with antiapoptotic activity (1). The H. pylori strain used here, SS1 (33) , is cag-PAI positive, but for unknown molecular reasons it does not deliver the effector protein CagA and uses cag-PAI-independent mechanisms to evoke immune responses (34, 35) . Thus we did not examine cagA expression.
In conclusion, our data suggest a model in which H. pylori uses chemotaxis to approach the gastric epithelial cells in such a way as to trigger apoptosis, and the combination of cell death with bacterial products promotes the development of a Th17-skewed immune response, as these same signals do in C. rodentium infections (24, 25) . Our model fits well with previous H. pylori experiments that demonstrated chemotaxis is needed for normal bacterial positioning within the gastric epithelium (4, 6) . Here we show that appropriate localization allows H. pylori to increase VacA expression (Fig. S5 ) and perhaps promote efficient delivery of this and other proapoptotic virulence factors. The simultaneous detection of the apoptotic cells and H. pylori bacterial ligands encourages innate immune cells to promote the Th17 cell-dominant response that we observed in wild-type infections (Figs. 3 and  4) . We conclude that one function of the chemotaxis system is to drive H. pylori to interact with the host and induce a pathological Th17 immune response that promotes chronic infection.
Materials and Methods
H. pylori Strains and Growth Conditions. Helicobacter pylori strain SS1 (33) and its isogenic mutants were used for all studies. SS1 was a gift of Jani O'Rourke (University of New South Wales, Sydney, Australia) and was minimally laboratory passaged before our experiments. SS1 ΔcheY::cat was created by replacing most of the cheY gene (HP1067) with the Campylobacter cat gene as described (5) . H. pylori was cultured as described in SI Materials and Methods.
Animal Infections. The University of California, Santa Cruz Institutional Animal Care and Use Committee approved all animal protocols and experiments. Female C57BL/6N mice (Helicobacter-free; Taconic Labs) were housed at the University of California, Santa Cruz animal facility. Mice were 6-8 wk old at the time of H. pylori infection, and age-matched uninfected mice were included in all experiments. Animals were intragastrically inoculated orally via a 20-gauge × 1.5 inch feeding needle with 500 μL containing ∼1 × 10 7 cfu/mL Brucella brothgrown H. pylori. After the infection period, the animals were killed via CO 2 narcosis, and the stomach was dissected, opened along the lesser curvature, and divided into longitudinal strips for preservation and analysis. The tissue pieces were (i) homogenized using the Bullet Blender (Next Advance) with 1. pylori infections) or three mice (mock infections). These tissue samples were collected 2 mo after inoculation, when the mice were colonized with 6.29 ± 1.1 log cfu/g wild-type or 5.72 ± 0.24 log cfu/g Che − H. pylori. *P < 0.05, Student t test. N.S., not significant.
(GIBCO), 1 M Hepes (Fisher), and 1× nonessential amino acid solution (Invitrogen), cells were stimulated for 4 h with the Leukocyte Activation Mixture (BD Biosciences) in a tissue culture CO 2 incubator at 37°C. Surface staining was performed with Alexa Fluor 488-CD3 (eBioscience), PeCy7-CD4 (eBioscience), and Alexa Fluor6 47-CD45 (Biolegend). After surface staining, cells were resuspended in a fixation/permeabilization solution kit (BD Cytofix/ cytoperm; BD Biosciences), and intracellular staining was performed with PE-IL17A (BD Pharmingen) following the manufacturer's protocol.
qPCR. Quantitative analysis of the cytokines in the mouse stomach was performed by real-time PCR. RNA was isolated from mouse stomach samples using the TRIzol RNA isolation protocol (GIBCO) and was converted to cDNA using SuperScript III First Strand Synthesis System (Invitrogen). The cDNA was measured in a qPCR reaction with SYBR green master mix (SABiosciences). Primers used for qPCR are given in Table S1 . Mammalian data were analyzed by the ΔΔ threshold cycle(Ct) method, as described in SI Materials and Methods. All samples were analyzed in triplicate, along with no-reverse transcriptase controls. The Mann-Whitney u test was used for statistical analysis.
TUNEL Assay. Samples used for the TUNEL assay were prepared from 14-μm-thick OCT-frozen sections mounted on glass slides (SuperFrost/Plus; Fisher 
